Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-26 @ 12:53 AM
Study NCT ID:
NCT00063934
Status:
TERMINATED
Last Update Posted:
2019-03-05
First Post:
2003-07-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-05
Start Date Type:
None
Primary Completion Date:
2008-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2003-07-08
First Submit QC Date:
None
Study First Post Date:
2003-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-07-10
Results First Submit QC Date:
None
Results First Post Date:
2012-08-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-08
Last Update Post Date:
2019-03-05
Last Update Post Date Type:
ACTUAL